| Microorganism |
MIC50
(μg/ml) |
MIC90
(μg/ml) |
Range
(μg/ml) |
Antimicrobial |
Reference |
| Pseudomonas aeruginosa (PU21) |
- |
- |
8 － ? |
Moxalactam (Latamoxef)  |
651 |
| Pseudomonas aeruginosa (PU21) |
- |
- |
16 － ? |
Ticarcillin (Ticar) |
651 |
| Pseudomonas aeruginosa (PU21) |
- |
- |
16 － ? |
Ticarcillin-Clavulanic acid |
651 |
| Pseudomonas aeruginosa (PU21) |
- |
- |
32 － ? |
Amoxicillin (Novamox, Amoxil) |
651 |
| Pseudomonas aeruginosa (PU21) |
- |
- |
>128 － ? |
Cefuroxime (Kefurox, Zinacef) |
651 |
| Pseudomonas aeruginosa (PU21) |
- |
- |
>128 － ? |
Cephalothin (Cefalotin, Keflin, Seffin) |
651 |
| Pseudomonas aeruginosa (PYOA + tobramycin-resistant) |
- |
- |
2 － ? |
Polymyxin B (Aerospin) |
238 |
| Pseudomonas aeruginosa (PYOA + tobramycin-resistant) |
- |
- |
4 － ? |
Polymyxin E (Colistin) |
238 |
| Pseudomonas aeruginosa (PYOA + tobramycin-resistant) |
- |
- |
8 － ? |
Tobramycin (Tobrex, Nebcin) |
238 |
| Pseudomonas aeruginosa (PYOA + tobramycin-resistant) |
- |
- |
32 － 63 |
Protamine |
238 |
| Pseudomonas aeruginosa (PYOA + tobramycin-resistant) |
- |
- |
63 － ? |
Polylysine (Polylysin) |
238 |
| Pseudomonas aeruginosa (PYOA + tobramycin-resistant) |
- |
- |
2000 － ? |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
238 |
| Pseudomonas aeruginosa (PYOA + tobramycin-resistant) |
- |
- |
>4000 － ? |
Chitosan |
238 |
| Pseudomonas aeruginosa (PYOA + tobramycin-resistant) |
- |
- |
>4000 － ? |
Clarithromycin (Biaxin) |
238 |
| Pseudomonas aeruginosa (PYOB + mucoid phenotype) |
- |
- |
2 － 4 |
Polymyxin E (Colistin) |
238 |
| Pseudomonas aeruginosa (PYOB + mucoid phenotype) |
- |
- |
2 － ? |
Polymyxin B (Aerospin) |
238 |
| Pseudomonas aeruginosa (PYOB + mucoid phenotype) |
- |
- |
2 － ? |
Tobramycin (Tobrex, Nebcin) |
238 |
| Pseudomonas aeruginosa (PYOB + mucoid phenotype) |
- |
- |
16 － 63 |
Protamine |
238 |
| Pseudomonas aeruginosa (PYOB + mucoid phenotype) |
- |
- |
32 － ? |
Polylysine (Polylysin) |
238 |
| Pseudomonas aeruginosa (PYOB + mucoid phenotype) |
- |
- |
1000 － ? |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
238 |
| Pseudomonas aeruginosa (PYOB + mucoid phenotype) |
- |
- |
>4000 － ? |
Chitosan |
238 |
| Pseudomonas aeruginosa (PYOB + mucoid phenotype) |
- |
- |
>4000 － ? |
Clarithromycin (Biaxin) |
238 |
| Pseudomonas aeruginosa (PYOC) |
- |
- |
2 － 4 |
Tobramycin (Tobrex, Nebcin) |
238 |
| Pseudomonas aeruginosa (PYOC) |
- |
- |
2 － ? |
Polymyxin B (Aerospin) |
238 |
| Pseudomonas aeruginosa (PYOC) |
- |
- |
4 － ? |
Polymyxin E (Colistin) |
238 |
| Pseudomonas aeruginosa (PYOC) |
- |
- |
16 － 32 |
Protamine |
238 |
| Pseudomonas aeruginosa (PYOC) |
- |
- |
32 － ? |
Polylysine (Polylysin) |
238 |
| Pseudomonas aeruginosa (PYOC) |
- |
- |
1000 － ? |
Azithromycin (Zithromax, Sumamed, Zitrocin) |
238 |